- Home
- USGO vs ANIX Comparison
USGO vs ANIX Comparison
Compare USGO & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USGO
- ANIX
- Stock Information
- Founded
- USGO 2015
- ANIX 1982
- Country
- USGO United States
- ANIX United States
- Employees
- USGO N/A
- ANIX N/A
- Industry
- USGO Precious Metals
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- USGO Basic Materials
- ANIX Health Care
- Exchange
- USGO Nasdaq
- ANIX Nasdaq
- Market Cap
- USGO 116.8M
- ANIX 95.7M
- IPO Year
- USGO 2023
- ANIX 1987
- Fundamental
- Price
- USGO $12.95
- ANIX $4.27
- Analyst Decision
- USGO Strong Buy
- ANIX Strong Buy
- Analyst Count
- USGO 2
- ANIX 3
- Target Price
- USGO $26.50
- ANIX $9.00
- AVG Volume (30 Days)
- USGO 160.5K
- ANIX 282.6K
- Earning Date
- USGO 11-12-2025
- ANIX 09-10-2025
- Dividend Yield
- USGO N/A
- ANIX N/A
- EPS Growth
- USGO N/A
- ANIX N/A
- EPS
- USGO N/A
- ANIX N/A
- Revenue
- USGO N/A
- ANIX N/A
- Revenue This Year
- USGO N/A
- ANIX N/A
- Revenue Next Year
- USGO N/A
- ANIX N/A
- P/E Ratio
- USGO N/A
- ANIX N/A
- Revenue Growth
- USGO N/A
- ANIX N/A
- 52 Week Low
- USGO $7.26
- ANIX $2.07
- 52 Week High
- USGO $14.93
- ANIX $4.98
- Technical
- Relative Strength Index (RSI)
- USGO 57.86
- ANIX 59.04
- Support Level
- USGO $12.75
- ANIX $4.21
- Resistance Level
- USGO $14.89
- ANIX $4.67
- Average True Range (ATR)
- USGO 0.89
- ANIX 0.36
- MACD
- USGO -0.15
- ANIX 0.02
- Stochastic Oscillator
- USGO 41.73
- ANIX 58.85
About USGO U.S. GoldMining Inc. Common stock
US Goldmining Inc is a mineral exploration and development company. It is focused on the exploration and development of a project located in Alaska, USA. The company's sole property is Whistler Project which is a gold-copper exploration project located in the Yentna Mining District, approximately 170 km northwest of Anchorage, Alaska.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.